Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome

Blood. 1995 May 1;85(9):2471-7.

Abstract

The Wiskott-Aldrich syndrome (WAS) is an X-linked (Xp11.22) recessive immunodeficiency syndrome characterized by susceptibility to opportunistic and pyogenic infections, thrombocytopenia, and eczema. Previous studies of obligate carriers of WAS documented that nonrandom inactivation of the X chromosome carrying the defective gene is observed in all peripheral blood cells. The existence of both abnormal platelets and lymphocytes is consistent with a defect that affects early hematopoietic precursors. We isolated CD34+ hematopoietic progenitor cells collected from obligate carriers of WAS by apheresis and used polymerase chain reaction analysis of a polymorphic variable number of repeats (VNTR) within the X-linked androgen receptor to document nonrandom inactivation. These data show that nonrandom inactivation of the X-chromosome in WAS-obligate carriers occurs early during hematopoietic differentiation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, CD / analysis
  • Antigens, CD34
  • Base Sequence
  • Blood Cells / ultrastructure*
  • Dosage Compensation, Genetic*
  • Female
  • Hematopoietic Stem Cells / ultrastructure*
  • Heterozygote
  • Humans
  • Minisatellite Repeats
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Receptors, Androgen / genetics
  • Wiskott-Aldrich Syndrome / genetics*
  • Wiskott-Aldrich Syndrome / pathology

Substances

  • Antigens, CD
  • Antigens, CD34
  • Receptors, Androgen